Elevated glucose levels and disrupted glucose metabolism in diabetes and Alzheimer’s disease(AD) may lead to insulin resistance, oxidative stress, and inflammation, affecting cognitive levels (Wang Y. et al., 2023). This evidence concerns the gene INS and diabetes mellitus.